Author

Naotoshi Nakamura

Nagoya UniversityORCID 0000-0002-4798-3660Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Naotoshi Nakamura1 paper · Kyoto University

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:clinical cohort / trial· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Shingo IwamiiD· 2 shared Akifumi Kamiyama· 1 shared Akira SugiyamaiD· 1 shared Aya NakayamaiD· 1 shared Chika YamamotoiD· 1 shared Daiki TatematsuiD· 1 shared Fumiya OmataiD· 1 shared Hiroshi MoriokaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Shingo IwamiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyPLoS ONEPeer-reviewedFeb 10, 2026

Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection

Yasuhisa Fujita, Marwa Akao, Daiki Tatematsu…·Shoya Iwanami

This study models oseltamivir's effects on viral shedding and symptom outcomes in experimental influenza infections using clinical trial data, finding no significant antiviral efficacy or dose-dependent effects.

DOI 10.1371/journal.pone.0342676

humanclinical cohort / trial

𝕏 PostBluesky

ImmunologybioRxivPreprintMar 1, 2025

Longitudinal analysis of antibody titers after primary and booster mRNA COVID-19 vaccination can identify individuals at risk for breakthrough infection

Hyeongki Park, Naotoshi Nakamura, Shô Miyamoto…·Masaharu Tsubokura

The paper analyzes longitudinal antibody titers post-vaccination to identify individuals at risk for breakthrough infections and identifies three population groups with distinct immune response patterns.

1 citation

humanproteomics

𝕏 PostBluesky